Access to healthcare

Bringing health to the whole world

Our objective

We aim to improve access to healthcare and deliver our medicines, services and education to patients around the world by tailoring our programmes to the communities they will serve. In some cases, this means looking at pricing; in others it involves overcoming other barriers to healthcare.

 


2017 highlights


5.7 million

patients accessed hypertension education, screening and treatment through Healthy Heart Africa

Launched

Healthy Lung Asia in nine Asian markets

9.0 million

patients benefited from patient access programmes


Strategy

Our access to healthcare strategy is made up of three elements:

  • Expanding disease prevention, awareness and treatment
  • Building capacity in areas with limited infrastructure
  • Improving affordability and access to underserved patients

Healthcare is a universal right and extending access to healthcare is a global goal to which we can significantly contribute. We work with our industry and partners to remove barriers to access, not build them. Our in-depth understanding of the healthcare systems of emerging countries and healthcare needs of the people who live there has helped us develop our science-based strategy. We develop our programmes to best meet the needs of local communities. In some cases, this means looking at pricing; in others it involves overcoming other barriers to healthcare.
 


Our stories


Early access to AstraZeneca investigational medicinal products

We recognise that there are circumstances where patients with serious or life-threatening diseases have exhausted all available therapeutic options and may not be eligible to enrol in one of our clinical trials. In such circumstances individual patients may be eligible for early access to an AstraZeneca investigational medicinal product.



Read more about access to healthcare in our Sustainability Report.

To view our policies, standards and positions, visit our Resources page